Niknezhad et al. (15) demonstrated that individuals with psoriasis are at an elevated risk for subclinical atherosclerosis and suggested that high-sensitivity C-reactive protein (hs-CRP) may serve as a valuable marker for assessing the future risk of cardiovascular diseases in this patient population. The gene discussed is CRP; the disease is psoriasis.